Pancreatic glucagon secretion during a short period of hemorrhage in anesthetized dogs.
Glucagon has been implicated in the hormonal metabolic response to hemorrhage. However, evidence for this has been obtained largely from observations of circulating plasma glucagon concentration. A clear increase in the pancreatic glucagon secretion remains to be demonstrated. Plasma concentrations of pancreatic immunoreactive glucagon (IRG) and insulin (IRI) were determined in portal venous and aortic blood, and plasma glucose in aortic blood. Dogs were bled (approximately 15 mL/kg) until aortic systolic blood pressure dropped to approximately 50% (70.5 +/- 8.1 mmHg, n = 7) (1 mmHg = 133.32 Pa) of its control value (135 +/- 7.1 mmHg, n = 7), and the hemorrhagic hypotension was maintained for 10 min. The net portal venous IRG delivery rate rose significantly and continued to increase during the hemorrhagic hypotension despite a significant fall in the portal venous blood flow. Aortic IRG increased significantly along with the increase in portal venous IRG delivery rate (r = 0.838, n = 42, p less than 0.01). The portal venous delivery rate of IRI decreased significantly in response to hemorrhage. The aortic IRG/IRI concentration ratio increased significantly during the hemorrhage-induced hypotension. Aortic glucose concentration increased significantly 5 min after hemorrhage and continued to rise until the end of the hemorrhagic hypotension. The present study demonstrates that the secretion of pancreatic glucagon actually increases during the early phase of hemorrhage. The results also indicate that the increase in aortic IRG during the hemorrhagic hypotension is due to the increased pancreatic glucagon secretion. It is suggested that the pancreatic glucagon may be involved in the early hyperglycemic response to hemorrhage.
Briand
R
R
Faculté de pharmacie, Université de Montréal, Que., Canada.
Gagné
J
J
Yamaguchi
N
N
D000758:Anesthesia; D000818:Animals; D001013:Aorta, Thoracic / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism; D004285:Dogs; D005934:Glucagon / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism; D006439:Hemodynamics / Q000187:drug effects; D006470:Hemorrhage / Q000378:metabolism / Q000503:physiopathology*; D007328:Insulin / Q000097:blood; D008297:Male; D010179:Pancreas / Q000378:metabolism*
D001786:Blood Glucose; D007328:Insulin; D005934:Glucagon; D005947:Glucose